Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67(1):358–380. https://doi.org/10.1002/hep.29086

Article  PubMed  Google Scholar 

Galle PR, Forner A, Llovet JM et al (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69(1):182–236. https://doi.org/10.1016/j.jhep.2018.03.019

Article  Google Scholar 

Liu KC, Lv WF, Lu D et al (2021) Initial experience of drug-eluting bead-transcatheter arterial chemoembolization after lipiodol-based transcatheter arterial chemoembolization failure for patients with advanced hepatocellular carcinoma. Cancer Manag Res. https://doi.org/10.2147/cmar.S332571

Article  PubMed  PubMed Central  Google Scholar 

Wang XH, Long LH, Cui Y et al (2020) MRI-based Radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma. Br J Cancer 122(7):1–8. https://doi.org/10.1038/s41416-019-0706-0

Article  CAS  Google Scholar 

Meng XP, Wang YC, Ju S et al (2020) Radiomics analysis on multiphase contrast-enhanced CT: a survival prediction tool in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Front Oncol 10:1196. https://doi.org/10.3389/fonc.2020.01196

Article  PubMed  PubMed Central  Google Scholar 

Hu K, Lu S, Li M et al (2020) A novel pre-treatment model predicting risk of developing refractoriness to transarterial chemoembolization in unresectable hepatocellular carcinoma. J Cancer 11(15):4589–4596. https://doi.org/10.7150/jca.44847

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cannella R, Cammà C, Matteini F et al (2022) Radiomics analysis on gadoxetate disodium-enhanced MRI predicts response to transarterial embolization in patients with HCC. Diagnostics 12(6):1308. https://doi.org/10.3390/diagnostics12061308

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ananchuensook P, Sriphoosanaphan S, Suksawatamnauy S et al (2022) Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization. BMC Gastroenterol 22(1):295. https://doi.org/10.1186/s12876-022-02366-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiraoka A, Kumada T, Kariyama K et al (2022) Simple scoring system for predicting TACE unsuitable among intermediate-stage hepatocellular carcinoma patients in the multiple systemic treatment era. Oncology 100(2):65–73. https://doi.org/10.1159/000520292

Article  CAS  PubMed  Google Scholar 

Han G, Berhane S, Toyoda H et al (2020) Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: a response-based approach. Hepatology 72(1):198–212. https://doi.org/10.1002/hep.31022

Article  CAS  PubMed  Google Scholar 

Kadalayil L, Benini R, Pallan L et al (2022) A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Ann Oncol 24(10):2565–2570. https://doi.org/10.1093/annonc/mdt247

Article  Google Scholar 

Forner A, Reig M, Bruix J et al (2018) Hepatocellular carcinoma. Lancet 391(10127):1301–1314. https://doi.org/10.1016/s0140-6736(18)30010-20

Article  PubMed  Google Scholar 

Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762. https://doi.org/10.1038/nrclinonc.2017.141

Article  PubMed  Google Scholar 

Miller KD, Nogueira L, Mariotto AB et al (2019) Cancer treatment and survivorship statistics. CA Cancer J Clin 69(5):363–385. https://doi.org/10.3322/caac.21565

Article  PubMed  Google Scholar 

Xu H, Guo W, Cui X et al (2019) Three-dimensional texture analysis based on PET/CT images to distinguish hepatocellular carcinoma and hepatic lymphoma. Front Oncol 9:844. https://doi.org/10.3389/fonc.2019.00844

Article  PubMed  PubMed Central  Google Scholar 

Fu S, Chen S, Liang C et al (2017) Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients’ selection of transcatheter arterial chemoembolization and sorafenib. Oncotarget 8(23):37855–37865. https://doi.org/10.18632/oncotarget.13675

Article  PubMed  Google Scholar 

Vosshenrich J, Zech CJ, Heye T et al (2021) Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models. Eur Radiol 31(6):4367–4376. https://doi.org/10.1007/s00330-020-07511-3

Article  PubMed  Google Scholar 

Wang XH, Long LH, Cui Y et al (2020) MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma. Br J Cancer 122(7):978–985. https://doi.org/10.1038/s41416-019-0706-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collins GS, Reitsma JB, Altman DG et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594. https://doi.org/10.1136/bmj.g7594

Article  PubMed  Google Scholar 

Lv WF, Liu KC, Lu D et al (2018) Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis. Cancer Manag Res 10:4719–4726. https://doi.org/10.2147/cmar.S166527

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Xu WJ, Yang Y et al (2022) Nomograms including the controlling nutritional status score in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation for prediction survival: a retrospective analysis. Br J Nutr 128(10):1966–1974. https://doi.org/10.1017/s000711452100492x

Article  CAS  PubMed  Google Scholar 

Noh B, Park YM, Kwon Y et al (2022) Machine learning-based survival rate prediction of Korean hepatocellular carcinoma patients using multi-center data. BMC Gastroenterol 22(1):85. https://doi.org/10.1186/s12876-022-02182-4

Article  PubMed  PubMed Central  Google Scholar 

Luo J, Huang Z, Wang M et al (2022) Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy. BMC Gastroenterol 22(1):108. https://doi.org/10.1186/s12876-022-02129-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun ZQ, Shi ZX, Xin YJ et al (2023) Contrast-enhanced CT imaging features combined with clinical factors to predict the effificacy and prognosis for transarterial chemoembolization of hepatocellular carcinoma. Acad Radiol. https://doi.org/10.1016/j.acra.2022.12.031

Article  PubMed  Google Scholar 

Fan XL, Wang YH, Chen YH et al (2023) Computed tomography texture analysis combined with preoperative clinical factors serve as a predictor of early efcacy of transcatheter arterial chemoembolization in hepatocellular carcinoma. Abdom Radiol 48(6):2008–2018. https://doi.org/10.1007/s00261-023-03868-3

Article  Google Scholar 

Aerts HJ (2016) The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol 2(12):1636–1642. https://doi.org/10.1001/jamaoncol.2016.2631

Article  PubMed  Google Scholar 

Liu Z, Meng X, Zhang H et al (2020) Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun 11(1):4308. https://doi.org/10.1038/s41467-020-18162-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun KY, Hu HT, Chen SL et al (2020) CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer 20(1):468. https://doi.org/10.1186/s12885-020-06970-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

General Office of National Health Commission (2022) Standard for diagnosis and treatment of primary liver cancer (2022 edition). J Clin Hepatol 38(2):288–303. https://doi.org/10.3969/j.issn.1001-5256.2022.02.009

Article  Google Scholar 

Villanueva A (2019) Hepatocellular carcinoma. N Encl J Med 380(15):1450–1462. https://doi.org/10.1056/NEJMra1713263

Article  CAS  Google Scholar 

Liu KC, Hao YH, Lv WF et al (2020) Transarterial chemoembolization combined with sorafenib in patients with BCLC stage C hepatocellular carcinoma. Drug Des Devel Ther 14:3461–3468. https://doi.org/10.2147/dddt.S248850

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Wang N, Wu J et al (2021) Radiomics analysis based on contrast-enhanced MRI for prediction of therapeutic response to transarterial chemoembolization in hepatocellular carcinoma. Front Oncol 11:582788. https://doi.org/10.3389/fonc.2021.582788

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Zhang Y, Fang Q et al (2021) Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. Eur J Nucl Med Mol Imag 48(8):2599–2614. https://doi.org/10.1007/s00259-020-05119-9

Article  CAS  Google Scholar